Olaplex Holdings, Inc. (NASDAQ:OLPX) is one of the High-Flying Penny Stocks to Buy. On March 10, Morgan Stanley reiterated an Equalweight rating on the stock with a price target of $1.40. The rating follows the company’s fiscal Q4 2025 earnings, which were reported on March 5, 2025. ​Olaplex Holdings, Inc. (NASDAQ:OLPX) grew its quarterly revenue by 4.35% year-over-year to $105.12 million and topped expectations by $764,140. The EPS of $0.01 stayed in-line with the consensus. The quarterly performance was ...

Hair care brand Olaplex has lost nearly 95% of its value since its IPO in 2021. Now it's trying to turn around its business, but analysts are split on whether the company is at an inflection point. In its earnings report last week.Olaplex reported a small increase in net sales for the quarter, but was pretty much flat for the year. Here's how the billion dollar company got here. Founded in 2014, it revolutionized the industry with new technology that focused on the hair's molecular level.In 2020, Olaplex wa ...

Hair care brand Olaplex has lost nearly 95% of its value since its IPO in 2021. Now it's trying to turn around its business, but analysts are split on whether the company is at an inflection point. In its earnings report last week.Olaplex reported a small increase in net sales for the quarter, but was pretty much flat for the year. Here's how the billion dollar company got here. Founded in 2014, it revolutionized the industry with new technology that focused on the hair's molecular level.In 2020, Olaplex wa ...

When prestige hair care brand Olaplex first debuted on the Nasdaq in late 2021, it surpassed pricing predictions and gained momentum fast.The company opened at $25 per share, an increase from its initial public offering pricing estimates. It was part of a broader group of retailers that went public that year amid an IPO boom. Olaplex hit its all-time high just a few months after its public debut, reaching a price of $29.41 on Jan. 3, 2022.But that run didn't last long.Since its IPO, Olaplex's stock performa ...

March 10 2026 – TheNewswire - BRONCO RESOURCES CORP. (TSX-V:BRON) (“Bronco” or the “Company”), is pleased to report the successful completion of a ground magnetic survey over the Main Zone at its Placer Mountain Gold Project, located in the Similkameen Mining Division, near Princeton, BC.The magnetic survey was completed to test imagery quality and resolution using industry standard GSM-19 “Overhauser” ground magnetometer instrumentation. The objective was to evaluate the level of detail achievable over a ...

Core Insights - Olaplex Holdings Inc. reported Q4 2025 financial results, achieving an adjusted EPS of $0.01 and stabilizing net sales at $423 million for the full year, marking an end to previous declines [1][2] - The company emphasized a strategic shift towards a 'Bonds and Beyond' vision, with Q4 revenue increasing by 4% year-over-year to $105.1 million, driven by a brand relaunch and a 14% rise in earned media value [1][2] Financial Performance - Q4 2025 revenue reached $105.1 million, reflecting a 4% growth compared to the previous year [1][2] - Full-year net sales for 2025 were reported at $423 million, stabilizing after a period of decline [1] Strategic Initiatives - The company acquired Pervala Bioscience and launched four of the top five prestige hair care products in 2025 [2] - A 'market blitz' program was implemented to reengage professional stylists, resulting in sell-through rates exceeding baseline expectations by mid-teen percentages [2] Future Outlook - The strategy for 2026 focuses on 'energizing hero products,' particularly with the launch of No. 3+, an evolution of the flagship bond repair treatment [3] - While Q1 EBITDA is expected to be impacted by front-loaded marketing costs, the company remains optimistic about its stabilized infrastructure and refreshed product pipeline supporting long-term growth [3]

Core Viewpoint - The article emphasizes the investment philosophy focused on identifying mispriced securities through understanding the financial drivers of companies, often revealed by DCF model valuation [1]. Group 1: Investment Philosophy - The investment approach is centered on small cap companies across US, Canadian, and European markets [1]. - The methodology is flexible, not confined to traditional value, dividend, or growth investing, but considers all prospects of a stock to assess risk-to-reward [1].

Core Insights - The company is transitioning from planning to execution under its "Bonds and Beyond" vision, focusing on brand demand, innovation, and excellence in execution [2] - Brand awareness increased by 7%, sentiment by 3%, and purchase intent is trending higher compared to pre-launch levels, indicating positive brand momentum [1] - The company reported a revenue growth of 4.3% in Q4 2025, reaching $105.1 million, despite a slight decline in total sell-through compared to the previous year [3] Brand Demand - A comprehensive visual identity relaunch and a "360-degree marketing engine" have been implemented, enhancing digital and physical touchpoints [1] - The company engaged nearly 4,000 creators and generated approximately 2 billion impressions through its 2025 campaigns, with earned media value increasing by 14% year-over-year [1] Financial Performance - Full-year net sales were flat at $423.0 million, with an adjusted EBITDA margin of 22.2%, despite increased spending on marketing and infrastructure [4][7] - Adjusted EBITDA for Q4 was $12.9 million, representing a 12.2% margin, down from 17.4% in Q4 2024 [15] - The company generated positive operating cash flow in Q4 and reported full-year operating cash flow of $58.7 million, ending the quarter with $318.7 million in cash [16] Market Trends - Professional channel sales rose 18.9% to $36.8 million in Q4, while specialty retail sales declined by 14.5% [6][19] - Direct-to-consumer (DTC) sales increased by 6.6% to $43.6 million in Q4, attributed to a revamped digital strategy [19] Innovation and Product Launches - The company launched its most significant product innovation, Nº.3PLUS, which is positioned as a fast, three-minute in-shower treatment [23] - The acquisition of Purvala Bioscience is expected to enhance the company's entry into additional health and beauty verticals [8] Strategic Priorities - For 2026, the company aims to energize hero products, fuel science-based innovation, and expand a diversified go-to-market model [21] - The company plans to front-load marketing for the new Nº.3PLUS launch, which may pressure Q1 EBITDA significantly [5][20] Geographic Performance - U.S. net sales decreased by approximately 3% in 2025, while international net sales increased by about 3%, supported by a new go-to-market strategy [12]

Financial Instruments and Interest Rates - As of December 31, 2025, the company had $354.8 million of outstanding variable rate loans under the 2022 Term Loan Facility, with a 1% change in the effective interest rate potentially impacting interest costs by approximately $3.5 million over the next 12 months[287]. - The company entered into the 2024 Interest Rate Cap with a notional amount of $400 million, which amortized to $200 million on July 31, 2025, at a strike rate of 5.00%[288]. Inflation and Operating Costs - Inflationary pressures, including increases in warehousing, transportation, labor, and raw material costs, may adversely affect the company's operating results and gross profit margins[289]. Taxation and Compliance - The company is subject to income taxes in the U.S. and the U.K., and changes in tax laws or regulations could materially affect its operating results and financial condition[185]. - The company is currently under examination in California for the 2020 and 2021 tax years, which may materially affect its operating results and financial condition[187]. - The company may face significant tax liabilities due to potential assessments and audits from state, local, and foreign jurisdictions[186]. - The company’s ability to utilize net operating loss carry-forwards may be limited, potentially resulting in increased future tax liabilities[188]. Operational Risks - The company is dependent on outsourced functions, and failures by these entities could adversely affect its business operations[193]. - The company’s operations could be disrupted by natural disasters, public health crises, or political instability, impacting its supply chain and financial condition[194]. Foreign Currency Exposure - The company has not engaged in hedging foreign currency transactions to date, and does not anticipate a material effect on its financial statements from a 10% change in the value of the U.S. dollar against other currencies[290].

Financial Data and Key Metrics Changes - For the full year of 2025, net sales were flat at $423 million, with a fourth quarter revenue growth of 4% and an adjusted EBITDA margin of 22.2% [6][25] - Fourth quarter net sales reached $105.1 million, a 4.3% increase year-over-year, while adjusted gross profit margin for the quarter was 70.6%, up 200 basis points year-over-year [25][30] - Adjusted EBITDA was $12.9 million for the quarter, representing a 12.2% margin, compared to 17.4% margin in the fourth quarter of 2024 [31] Business Line Data and Key Metrics Changes - Professional channel sales increased 18.9% year-over-year in the fourth quarter to $36.8 million, with net sales increasing 5.5% for the year [26] - Specialty retail declined 14.5% year-over-year in the quarter to $24.7 million, with net sales decreasing 8.3% for the year [27] - Direct-to-consumer sales increased 6.6% year-over-year to $43.6 million in the quarter, with net sales increasing 3.1% for the year [28] Market Data and Key Metrics Changes - U.S. net sales were down approximately 3%, while international sales were up approximately 3% for the year [29] - The company noted that premium haircare is forecasted to grow at 6%-7% through 2029, indicating a healthy market environment [8] Company Strategy and Development Direction - The company introduced its "Bonds and Beyond" vision, focusing on generating brand demand, harnessing innovation, and executing with excellence [7][8] - The strategic acquisition of Purvala Bioscience aims to enhance the company's innovation capabilities and enter additional verticals across health and beauty [13] - In 2026, the company plans to energize hero products, fuel science-based innovation, and expand its diversified go-to-market model [16][18] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's transformation progress, noting that while total fourth quarter sell-through was slightly lower compared to the prior year, there were positive trends exiting December [25][34] - The outlook for 2026 includes expected net sales in the range of approximately -2% to +3% versus fiscal year 2025, with adjusted gross profit margin between 71% and 72% [32][33] - Management acknowledged the uncertain global macroeconomic environment and shifting consumer sentiment as factors to monitor [33] Other Important Information - The company ended the quarter with cash and cash equivalents of $318.7 million and debt of $352.3 million, reflecting strong management of working capital [31][32] - The company is focused on optimizing investments and refining marketing spend in 2026 after significant investments in 2025 [30][36] Q&A Session Summary Question: Discrepancy between specialty retail and DTC performance - Management noted that specialty retail outperformed expectations in the fourth quarter, with sequential improvement in sell-through velocity [40][41] Question: Expectations for the first quarter and sales cadence - Management indicated that the first quarter revenue is expected to be below the range due to strategic phasing of innovation shipments and increased marketing spend [45][46] Question: Opportunities in additional verticals across beauty - Management highlighted the potential for innovation in hair care and the importance of hero SKUs to attract new consumers [53][56] Question: Strong performance in the professional channel - Management attributed the success to a combination of innovation, education programs, and international realignment [60][62] Question: International growth performance - Management expressed optimism about the international strategy, indicating strong year-over-year growth without breaking out specific regional performance [64]